JSPR logo

Jasper Therapeutics, Inc. (JSPR)

Profile

Full Name

Jasper Therapeutics, Inc.

Ticker

NASDAQ: JSPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 10, 2020

Indexes

Not included

Website

https://jaspertx.com

Employees

64

Key Details

Price

$2.38(-2.06%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$4.89(+20.87% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.38
    JSPR price is $2.38

    30-Day Relative Volume

    0.99
    JSPR 30-day relative volume is 0.99

    Price Performance

    Price Most recent change

    -2.06%
    JSPR price was down -2.06% on Sep 15, 2025

    Price YTD change

    -88.87%
    JSPR price is down -88.87% since January 1st

    Price 1-year change

    -89.63%
    JSPR price is down -89.63% year-on-year

    Price 3-year change

    -79.66%
    JSPR price is down -79.66% over the past 3 years

    Price Range

    Price All-time high

    $188.80
    JSPR price is currently -98.74% below its historical high of $188.80

    Price 3-year low

    $2.27
    JSPR price is currently +5.08% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $38.68M
    JSPR market capitalization is $38.68 million

    Market cap 3-year change

    -9.88%
    JSPR market capitalization is down -9.88% over the past 3 years

    Market cap All-time high

    $620.94M
    JSPR market capitalization is currently -93.77% below its historical high of $620.94 million

    Market cap sector rank

    29.28%
    JSPR market capitalization is higher than 29.28% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +7.6%
    JSPR shares outstanding is up +7.6% year-on-year

    Shares Outstanding 3-Year Change

    +343.03%
    JSPR shares outstanding is up +343.03% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    JSPR beta is 1.27

    200-day SMA

    $7.13
    JSPR price is currently -66.60% below its 200-day simple moving average

    50-day SMA

    $2.96
    JSPR price is currently -19.57% below its 50-day simple moving average

    RSI

    27.37
    JSPR 14-day relative strength index is 27.37

    Volume

    0.99
    JSPR 30-day relative volume is 0.99

    ATR

    $0.18
    JSPR average true range is $0.18

    10-day Historical Volatility

    25.67%
    JSPR 10-day historical volatility is 25.67%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    JSPR annual revenue is $0.00

    Revenue Analysts estimate

    -
    JSPR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    JSPR annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    JSPR annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$4.89
    JSPR annual earnings per share is -$4.89

    EPS Analysts estimate

    -$5.31
    JSPR annual earnings per share is currently -7.88% lower than the consensus analysts' forecast

    EPS 1-year change

    +20.87%
    JSPR annual earnings per share is up +20.87% year-on-year

    EPS Sector rank

    20.15%
    JSPR annual earnings per share is higher than 20.15% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.37M
    JSPR annual gross profit is -$1.37 million

    Gross margin

    -
    JSPR annual gross profit margin value is unknown

    Operating profit

    -$76.24M
    JSPR annual operating income is -$76.24 million

    Operating margin

    -
    JSPR annual operating profit margin value is unknown

    Net income

    -$71.27M
    JSPR annual net profit is -$71.27 million

    Net margin

    -
    JSPR annual net profit margin value is unknown

    Expenses

    Total expenses

    $76.24M
    JSPR annual total expenses is $76.24 million

    Operating expenses

    $76.24M
    JSPR annual total operating expenses is $76.24 million

    Cost of goods sold

    $1.37M
    JSPR annual cost of goods sold is $1.37 million

    Selling, general & administrative expenses

    $20.42M
    JSPR annual SGA is $20.42 million

    Depreciation and amortization

    $1.37M
    JSPR annual depreciation & amortization is $1.37 million

    Interest expense

    $0.00
    JSPR annual interest expense is $0.00

    Income tax

    -$1.49M
    JSPR annual income tax is -$1.49 million

    EBIT & EBITDA

    EBIT

    -$76.24M
    JSPR annual earnings before interest & taxes is -$76.24 million

    EBITDA

    -$74.87M
    JSPR annual EBITDA is -$74.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $79.90M
    JSPR annual total assets is $79.90 million

    Non current assets

    $4.09M
    JSPR annual long term assets is $4.09 million

    Current assets

    $75.81M
    JSPR annual total current assets is $75.81 million

    Cash and cash equivalents

    $71.64M
    JSPR annual cash & cash equivalents is $71.64 million

    Accounts receivable

    -
    JSPR annual accounts receivable value is unknown

    Inventory

    $0.00
    JSPR annual inventory is $0.00

    Liabilities

    Total liabilities

    $15.96M
    JSPR annual total liabilities is $15.96 million

    Long term liabilities

    $2.99M
    JSPR annual total long term liabilities is $2.99 million

    Current liabilities

    $15.24M
    JSPR annual total current liabilities is $15.24 million

    Accounts payable

    $4.03M
    JSPR annual accounts payable is $4.03 million

    Debt

    Total debt

    $1.81M
    JSPR annual total debt is $1.81 million

    Total debt 1-year change

    -34.92%
    JSPR annual total debt is down -34.92% year-on-year

    Long term debt

    $724.00K
    JSPR annual long term debt is $724.00 thousand

    Short term debt

    $1.09M
    JSPR annual short term debt is $1.09 million

    Equity & Capital

    Shareholders equity

    $61.67M
    JSPR annual stockholders equity is $61.67 million

    Book value

    $61.67M
    JSPR annual book value is $61.67 million

    Retained earnings

    -$240.87M
    JSPR annual retained earnings is -$240.87 million

    Working capital

    $60.57M
    JSPR annual working capital is $60.57 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$62.60M
    JSPR annual cash flow from operations is -$62.60 million

    Cash from operations 1-year change

    -20.23%
    JSPR annual cash flow from operations is down -20.23% year-on-year

    Cash from investing

    -$532.00K
    JSPR annual cash flow from investing activities is -$532.00 thousand

    Cash from investing 1-year change

    -99.25%
    JSPR annual cash flow from investing activities is down -99.25% year-on-year

    Cash from financing

    $47.88M
    JSPR annual cash flow from financing activities is $47.88 million

    Cash from financing 1-year change

    -52.58%
    JSPR annual cash flow from financing activities is down -52.58% year-on-year

    CAPEX

    CAPEX

    $552.00K
    JSPR annual capital expenditures is $552.00 thousand

    CAPEX 1-year change

    +106.74%
    JSPR annual capital expenditures is up +106.74% year-on-year

    Free Cash Flow

    Free cash flow

    -$63.15M
    JSPR annual free cash flow is -$63.15 million

    Free cash flow 1-year change

    -20.67%
    JSPR annual free cash flow is down -20.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    JSPR annual gross profit margin value is unknown

    Operating margin

    -
    JSPR annual operating profit margin value is unknown

    Net margin

    -
    JSPR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -81.32%
    JSPR annual return on assets is -81.32%

    ROE

    -101.73%
    JSPR annual return on equity is -101.73%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    JSPR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    JSPR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.65
    JSPR price to book ratio is 1.65

    PB ratio Sector rank

    48.32%
    JSPR price to book ratio is higher than 48.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    JSPR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    JSPR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.33M
    JSPR enterprise value is $1.33 million

    Enterprise value Sector rank

    12.35%
    JSPR enterprise value is higher than 12.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.01
    JSPR EV/EBITDA is -0.01

    EV/EBITDA Sector rank

    64.13%
    JSPR EV/EBITDA is higher than 64.13% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.98
    JSPR annual current ratio is 4.98

    Quick ratio

    4.98
    JSPR annual quick ratio is 4.98

    Leverage

    Debt to equity

    0.03
    JSPR annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    JSPR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    JSPR piotroski f-score value is unknown

    Altman Z-Score

    -5.01
    JSPR altman z-score is -5.01

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 UBS
    Buy
    Jul 8, 25 JMP Securities
    Market Outperform
    Jul 8, 25 Evercore ISI Group
    Outperform
    Jul 8, 25 BMO Capital
    Market Perform
    Jul 7, 25 William Blair
    Market Perform
    Jul 7, 25 HC Wainwright & Co.
    Buy
    Jul 7, 25 Cantor Fitzgerald
    Neutral
    Jul 7, 25 BTIG
    Buy
    May 15, 25 Oppenheimer
    Outperform
    May 13, 25 UBS
    Buy

    Institutional Ownership

    Screeners with JSPR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Jasper Therapeutics, Inc.?
    • Does Jasper Therapeutics, Inc. pay dividends?
    • What sector is Jasper Therapeutics, Inc. in?
    • What industry is Jasper Therapeutics, Inc. in?
    • What country is Jasper Therapeutics, Inc. based in?
    • When did Jasper Therapeutics, Inc. go public?
    • Is Jasper Therapeutics, Inc. in the S&P 500?
    • Is Jasper Therapeutics, Inc. in the NASDAQ 100?
    • Is Jasper Therapeutics, Inc. in the Dow Jones?
    • When was Jasper Therapeutics, Inc.'s last earnings report?
    • When does Jasper Therapeutics, Inc. report earnings?

    What is the ticker symbol for Jasper Therapeutics, Inc.?

    The ticker symbol for Jasper Therapeutics, Inc. is NASDAQ:JSPR

    Does Jasper Therapeutics, Inc. pay dividends?

    No, Jasper Therapeutics, Inc. does not pay dividends

    What sector is Jasper Therapeutics, Inc. in?

    Jasper Therapeutics, Inc. is in the Healthcare sector

    What industry is Jasper Therapeutics, Inc. in?

    Jasper Therapeutics, Inc. is in the Biotechnology industry

    What country is Jasper Therapeutics, Inc. based in?

    Jasper Therapeutics, Inc. is headquartered in United States

    When did Jasper Therapeutics, Inc. go public?

    Jasper Therapeutics, Inc.'s initial public offering (IPO) was on January 10, 2020

    Is Jasper Therapeutics, Inc. in the S&P 500?

    No, Jasper Therapeutics, Inc. is not included in the S&P 500 index

    Is Jasper Therapeutics, Inc. in the NASDAQ 100?

    No, Jasper Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Jasper Therapeutics, Inc. in the Dow Jones?

    No, Jasper Therapeutics, Inc. is not included in the Dow Jones index

    When was Jasper Therapeutics, Inc.'s last earnings report?

    Jasper Therapeutics, Inc.'s most recent earnings report was on August 13, 2025

    When does Jasper Therapeutics, Inc. report earnings?

    The next expected earnings date for Jasper Therapeutics, Inc. is November 6, 2025
    On this page